Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening
Top Cited Papers
- 6 July 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 48 (32) , 7732-7745
- https://doi.org/10.1021/bi9006435
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- A Robotic Platform for Quantitative High-Throughput ScreeningASSAY and Drug Development Technologies, 2008
- 2-Aminothienopyridazines as Novel Adenosine A1Receptor Allosteric Modulators and AntagonistsJournal of Medicinal Chemistry, 2008
- Development of a 384-Well Colorimetric Assay to Quantify Hydrogen Peroxide Generated by the Redox Cycling of Compounds in the Presence of Reducing AgentsASSAY and Drug Development Technologies, 2008
- Differentiating Alzheimer disease-associated aggregates with small moleculesNeurobiology of Disease, 2007
- Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathiesProceedings of the National Academy of Sciences, 2007
- High throughput screening for small molecule inhibitors of heparin-induced tau fibril formationPublished by Elsevier ,2007
- Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical librariesProceedings of the National Academy of Sciences, 2006
- A detergent-based assay for the detection of promiscuous inhibitorsNature Protocols, 2006
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- Structure, Microtubule Interactions, and Paired Helical Filament Aggregation by Tau Mutants of Frontotemporal DementiasBiochemistry, 2000